Urszula Mantaj

592 total citations
24 papers, 185 citations indexed

About

Urszula Mantaj is a scholar working on Obstetrics and Gynecology, Endocrinology, Diabetes and Metabolism and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Urszula Mantaj has authored 24 papers receiving a total of 185 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Obstetrics and Gynecology, 10 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Urszula Mantaj's work include Gestational Diabetes Research and Management (18 papers), Diabetes Management and Research (10 papers) and Pregnancy and preeclampsia studies (6 papers). Urszula Mantaj is often cited by papers focused on Gestational Diabetes Research and Management (18 papers), Diabetes Management and Research (10 papers) and Pregnancy and preeclampsia studies (6 papers). Urszula Mantaj collaborates with scholars based in Poland, United States and United Kingdom. Urszula Mantaj's co-authors include Ewa Wender-Ożegowska, Paweł Gutaj, Agnieszka Zawiejska, Rafał Sibiak, Katarzyna Ożegowska, Katarzyna Wróblewska‐Seniuk, Jacek Brązert, Jan Matysiak, Szymon Plewa and Dorota Zozulińska‐Ziółkiewicz and has published in prestigious journals such as PLoS ONE, Diabetes and Metabolism.

In The Last Decade

Urszula Mantaj

21 papers receiving 181 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Urszula Mantaj Poland 9 120 67 47 40 31 24 185
Sharon Mackin United Kingdom 5 165 1.4× 52 0.8× 69 1.5× 87 2.2× 20 0.6× 7 278
Jason Kong Canada 7 97 0.8× 97 1.4× 51 1.1× 24 0.6× 24 0.8× 9 182
Loretta Giunta Italy 7 138 1.1× 18 0.3× 59 1.3× 34 0.8× 8 0.3× 8 238
Sharona Azriel Spain 6 40 0.3× 69 1.0× 99 2.1× 22 0.6× 62 2.0× 15 194
K. Boynukalin Türkiye 8 82 0.7× 14 0.2× 15 0.3× 27 0.7× 10 0.3× 26 195
Albert Carrión Spain 9 46 0.4× 34 0.5× 118 2.5× 7 0.2× 8 0.3× 36 213
S. Davis United States 8 13 0.1× 83 1.2× 22 0.5× 43 1.1× 49 1.6× 14 209
Shauna Reinblatt Canada 10 114 0.9× 52 0.8× 26 0.6× 142 3.5× 9 0.3× 18 350
J Rodriguez Spain 7 93 0.8× 41 0.6× 17 0.4× 5 0.1× 19 0.6× 14 164
A. Bagnoli Italy 7 101 0.8× 47 0.7× 41 0.9× 12 0.3× 15 0.5× 7 312

Countries citing papers authored by Urszula Mantaj

Since Specialization
Citations

This map shows the geographic impact of Urszula Mantaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Urszula Mantaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Urszula Mantaj more than expected).

Fields of papers citing papers by Urszula Mantaj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Urszula Mantaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Urszula Mantaj. The network helps show where Urszula Mantaj may publish in the future.

Co-authorship network of co-authors of Urszula Mantaj

This figure shows the co-authorship network connecting the top 25 collaborators of Urszula Mantaj. A scholar is included among the top collaborators of Urszula Mantaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Urszula Mantaj. Urszula Mantaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wender-Ożegowska, Ewa, et al.. (2025). sFlt‐1/PlGF Ratio in the Prediction of Preeclampsia in Pregnant Women With Diabetic Kidney Disease. Journal of Diabetes Research. 2025(1). 3987453–3987453.
2.
Sibiak, Rafał, et al.. (2024). Functional analysis of daily glycemic profiles and excessive fetal growth in pregnant patients with well-controlled type 1 diabetes: Retrospective cohort. Diabetes Research and Clinical Practice. 207. 111088–111088. 3 indexed citations
3.
Mantaj, Urszula, et al.. (2024). Physical activity, gestational weight gain in obese patients with early gestational diabetes and the perinatal outcome – a randomised–controlled trial. BMC Pregnancy and Childbirth. 24(1). 104–104. 4 indexed citations
4.
Sibiak, Rafał, et al.. (2024). Placental expression of GLUT‐1, GLUT‐3, and GLUT‐4 mRNA and transcriptome profiling in pregnant women with diabetes. Journal of Diabetes Investigation. 16(3). 543–554.
5.
Sibiak, Rafał, et al.. (2023). Continuous glucose monitoring parameters in pregnancy-related complications in patients with type 1 diabetes: a retrospective cohort study. Polskie Archiwum Medycyny Wewnętrznej. 133(11). 9 indexed citations
6.
Gutaj, Paweł, et al.. (2022). Corin—The Early Marker of Preeclampsia in Pregestational Diabetes Mellitus. Journal of Clinical Medicine. 12(1). 61–61. 4 indexed citations
7.
Sibiak, Rafał, et al.. (2022). The utility of novel CGM metrics in the LGA newborn prediction in women with type 1 diabetes – assessment of the cut-off values. Metabolism. 128. 155017–155017. 1 indexed citations
8.
Sibiak, Rafał, et al.. (2021). Novel Continuous Glucose Monitoring Metrics and Large-for-Gestational-Age Risk: An Exploratory Retrospective Cohort Study in Pregnancies with Type 1 Diabetes. Diabetes Technology & Therapeutics. 24(1). 42–53. 21 indexed citations
9.
10.
Ludwig‐Słomczyńska, Agnieszka H., Michał Seweryn, Przemysław Kapusta, et al.. (2021). The transcriptome-wide association search for genes and genetic variants which associate with BMI and gestational weight gain in women with type 1 diabetes. Molecular Medicine. 27(1). 6–6. 4 indexed citations
11.
Ożegowska, Katarzyna, et al.. (2021). Serum Metabolomics in PCOS Women with Different Body Mass Index. Journal of Clinical Medicine. 10(13). 2811–2811. 14 indexed citations
12.
Ludwig‐Słomczyńska, Agnieszka H., Michał Seweryn, Przemysław Kapusta, et al.. (2020). Mitochondrial GWAS and association of nuclear – mitochondrial epistasis with BMI in T1DM patients. BMC Medical Genomics. 13(1). 97–97. 13 indexed citations
13.
Wender-Ożegowska, Ewa, et al.. (2020). Pregnancy Outcomes in Women with Long-Duration Type 1 Diabetes—25 Years of Experience. Journal of Clinical Medicine. 9(10). 3223–3223. 9 indexed citations
14.
15.
Mantaj, Urszula, Paweł Gutaj, Katarzyna Ożegowska, et al.. (2019). Continuous subcutaneous insulin infusion reduces neonatal risk in pregnant women with type 1 diabetes mellitus. Ginekologia Polska. 90(3). 154–160. 10 indexed citations
16.
Gutaj, Paweł, et al.. (2019). Maternal risk factors for neonatal acidosis in women with type 1 diabetes. Polskie Archiwum Medycyny Wewnętrznej. 129(5). 316–320. 1 indexed citations
17.
Gutaj, Paweł, Agnieszka Zawiejska, Urszula Mantaj, & Ewa Wender-Ożegowska. (2017). Determinants of preeclampsia in women with type 1 diabetes. Acta Diabetologica. 54(12). 1115–1121. 29 indexed citations
18.
Zawiejska, Agnieszka, et al.. (2013). Multiple daily injections of insulin versus continuous subcutaneous insulin infusion for pregnant women with type 1 diabetes. Australian and New Zealand Journal of Obstetrics and Gynaecology. 53(2). 130–135. 25 indexed citations
19.
Wender-Ożegowska, Ewa, Agnieszka Zawiejska, Katarzyna Ożegowska, et al.. (2013). Multiple Daily Injections of Insulin Versus Continuous Subcutaneous Insulin Infusion for Pregnant Women With Type 1 Diabetes. Obstetrical & Gynecological Survey. 68(10). 675–677.
20.
Gutaj, Paweł, Ewa Wender-Ożegowska, Urszula Mantaj, Agnieszka Zawiejska, & Jacek Brązert. (2011). [Maternal body mass index and gestational weight gain and their association with perinatal outcome in women with gestational diabetes].. PubMed. 82(11). 827–33. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026